A total of 343 Bangladeshi children, age 6 to 59 months old, with severe acute malnutrition [SAM, weight-for-height Z (WHZ) score <-3 and/or bipedal edema, mid upper arm circumference (MUAC) <11.5 cm] were enrolled in a randomized, double-blind study to compare the efficacy of two locally-produced ready-to-use therapeutic foods (RUTFs) and a commercially available RUTF on the rate of weight gain after initial stabilization using a hospital-based, standardized management protocol (1) (ClinicalTrials.gov identifier: NCT01889329). The study was approved by the Ethical Review Committee at the icddr,b and written informed consent was obtained from the parents or guardians of the study participants. Recruitment occurred at three study locations: Dhaka Hospital of icddr,b, RADDA MCH FP Center Mirpur, Dhaka and TDH, Kurigram. 54 of the children (aged 6-24 months) were enrolled in a substudy that involved longitudinal fecal and blood sampling over a one-year period following enrollment. After acute stabilization, children were randomized to one of the three treatment arms; 20 children received a commercial RUTF, Plumpy'Nut (Nutriset), 19 were treated with a rice-lentil RUTF and 15 were given a chickpea-containing RUTF, each providing ~200kcal/kg/day. The rice-lentil and chickpea prototypes were designed to (i) to contain affordable, locally available ingredients (2), (ii) meet the macro-and micronutrient specifications for RUTF, and (iii) have acceptable organoleptic properties. Children were discharged after successful treatment, which was defined as having an edema-free WHZ score ≥ -2. The study protocol included three blood draws; one at enrollment, another at the end of the therapeutic intervention, and a final sample at 6-months post-intervention.
vortexed vigorously for 10 minutes. The two phases were separated by centrifugation (4,000 x g for 5 minutes). The upper organic layer was transferred into another vial and a second 1 mL diethyl ether extraction was performed. After combining the two ether extracts, a 60 µL aliquot was mixed with 20 µL N-tert.-butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA) in a GC auto-sampler vial with a 100 µL glass insert and the mixture was incubated for 2 hours at room temperature. Derivatized samples (1 µL aliquots) were injected with 100:1 split into an Agilent 7890A gas chromatography system coupled with a 5977B mass spectrometer detector. Analyses were carried on a HP-5MS capillary column (30 m x 0.25 mm, 0.25 µm film thickness, Agilent J & W Scientific, Folsom, CA) using electronic impact (70 eV) as the ionization mode. Helium was used as a carrier gas at a constant flow rate of 1 mL/minute and the solvent delay time was set to 3.5 minutes. The column head-pressure was 10 p.s.i. The temperatures of the injector, transfer line, and quadrupole were 270 °C, 280 °C and 150 °C, respectively. The GC oven was programmed as follows: 45 °C held for 2.25 minutes, increased to 200 °C at a rate of 20 °C/minute, then to 300 °C at a rate of 100 °C/minute, and finally held at 300 °C for 3 minutes.
Liquid Chromatography Quadrupole Time-of-Flight Mass spectrometry (LC-QTOF-MS) -Cecal contents were homogenized in 20 vol/wt of methanol. After centrifugation (8,000 x g, 4 o C), a 200 μL aliquot of the supernatant was dried in a centrifugal evaporator. Samples were resuspended in 80 µL of 95% methanol, centrifuged (8,000 x g, 4 o C for 5 minutes) to clarify, and transferred to auto-sampler vials with 100 µL glass inserts. Untargeted metabolomics was performed using an Agilent 1290 LC system coupled to an Agilent 6545 Q-TOF mass spectrometer (Santa Clara, CA). A 5 μL aliquot of each sample prepared for positive ESI ionization was injected onto a BEH C18 column (2.1 × 150 mm, 1.7 μm; Waters Corp., Milford, MA), which was heated to 35 °C. The mobile phase consisted of 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B). A flow rate of 0.3 mL/minute was applied and the following gradient program was employed; 0 to 14 minutes, mobile phase B eluted from 5% to 100% and then kept for 3 minutes at 100% of B. An equilibration time of 3 minutes was used. To provide accurate mass measurements, reference compounds with m/z 121.0509 and 922.0098 were automatically delivered using a dual ESI source during analyses. Mass accuracy was generally better than 4 ppm. N-acetyl-2,3-dehydro-2-deoxyneuraminic acid was identified in the cecal contents of colonized mice fed the S-BMO supplemented M8 diet based on MS/MS analysis and co-migration with a standard (Sigma).
Micro-computed tomography (µCT) of bone -The femur and tibia were harvested from the right rear leg of each animal and cleaned of muscle and connective tissue. Femurs were fixed for ≥48 hours in 70% ethanol, then embedded in 2% agarose and subsequently scanned with a μCT 40 desktop cone beam instrument (ScanCO Medical, Brüttisellen, Switzerland). For analyses of cortical bone, 100 slices were taken for each sample in the transverse plane, with a 6 µm voxel size (high resolution). For all cortical scans, slices began at the midpoint of the femur and extended toward the distal femur. Boundaries of, and thresholds for bone were drawn manually using μCT 40 software. Volumetric parameters were quantified using software associated with the ScanCO instrument.
Histochemical and dynamic histomorphometric analyses of bone -Nine days prior to sacrifice, mice received Calcein green dye (10 mg/kg) via intraperitoneal injection. Seven days later, mice were given Alizarin red dye (30 mg/kg) intraperitoneally. At the time of euthanasia, tibia were isolated and muscle and tissue were removed prior to fixation in 70% ethanol. Fixed tibias were embedded in methylmethacrylate and cut into 5 μm thick longitudinal sections and stained for tartrate resistant acid phosphatase (TRAP) and with hematoxylin, or left unstained for imaging of calcein and alizarin fluorescence. The longitudinal sections were imaged at 100x magnification with a NanoZoomer 2.0-HT system (Hamamatsu Photonics, Shizuoka, Japan). The resulting images were analyzed using BioQuant OSTEO software (BIOQUANT Image Analysis Co., Nashville, TN). For TRAP-stained sections, the region of interest for analysis of trabecular bone was defined as the 2-dimensional area beginning 750 μm proximal to the distal growth plate, extending to the very proximal edge of the growth plate, and spanning the full width of the bone. Osteoclasts were identified as pink TRAP-positive cells. Regions located adjacent to the growth plate where osteoclast density was too high to accurately count cells were excluded from the analysis. For dynamic histomorphometry, the distance between calcein-and alizarin-stained bone surfaces was measured as the mineral apposition rate. Total mineralizing bone surface was also assessed, and bone formation rate was calculated as the mineral apposition rate divided by mineralizing bone surface.
Flow Cytometry -Lamina propria cell populations were recovered from the colon by thoroughly rinsing the tissue in Hank's Balanced Salt Solution (HBSS) supplemented with 5% v/v fetal bovine serum (FBS, Gibco) and 25 mM HEPES. Epithelial cells were removed by gentle shaking for 40 minutes at 37ºC in HBSS supplemented with 15 mM HEPES, 5 mM EDTA, 10% FBS and 1 mM dithiothreitol. Halfway through the incubation, colonic samples were transferred to fresh buffer. At the conclusion of the epithelial dissociation, samples were finely chopped with scissors and then digested for 40 minutes at 37 o C with gentle shaking in RPMI 1640 containing 0.17 mg/mL Liberase TL (Roche) and 30 µg/mL DNase (Sigma). Samples were centrifuged at 300 x g for 5 minutes at 4 o C. The resulting pellet was resuspended in HBSS with 5% FBS and 25 mM HEPES and passed through a 100 µm pore diameter cell strainer followed by a 40 µm pore diameter cell strainer (Fisher Scientific). Cells that passed through the strainers were collected by centrifugation (300 x g for 5 minutes at 4 o C) and resuspended in 300 µL of HBSS/5% FBS/25 mM HEPES. 100 µL aliquots of the cell suspension prepared from each colon was placed in wells of a 96-well round bottom plate for antibody staining.
For flow cytometry of bone marrow cells, the femur and tibia were harvested from the left rear leg of each animal and cleaned of all muscle and connective tissue. Bones were carefully cut just below the knee (tibia) and just above the knee (femur) and placed cut side down in a 0.5 mL tube with an added hole from a 22g needle. This tube was then placed inside a 1.5 mL tube which was centrifuged (8,000 x g at room temperature for 10 seconds). Pelleted bone marrow cells were resuspended in Phosphate Buffered Saline (PBS) containing 2% v/v FBS and aliquoted into wells of a 96-well plate.
Colonic cells were initially blocked with TruStain fcX (anti-mouse CD16/32 antibody, BioLegend) for 10 minutes at room temperature. Bone marrow cells were not treated with Fc block since CD16 and CD32 antigens were used to characterize progenitor cell populations. Cells were centrifuged (300 x g for 5 min at 4 o C) and resuspended in 100 µL of LIVE/DEAD Fixable Aqua solution (Life Technologies) for 20 minutes at room temperature. Cells were subsequently washed twice with 1X PBS/2% FBS and stained with fluorochrome-conjugated antibodies before fixation in 4% paraformaldehyde.
Antibodies used for flow cytometry and their sources were as follows: CD11c (clone N418, Biolegend); Ly6C (clone AL-21, BD Biosciences); SiglecF (Clone E50-2440, BD Biosciences); CD11b (clone M1/70, Biolegend); Ly6G (clone 1A8, Biolegend); CD16/32 (clone 93, Biolegend); cKit (clone ACK2, Biolegend); CD127 (clone A7R34, Biolegend); CD34 (clone RAM34, BD Biosciences); Sca-1 (clone D7, Biolegend); CD135 (clone A2F10, Biolegend); TCRβ (clone H57-597, BD Biosciences); CD3e (17A2, BD Biosciences); CD49b (clone DX5, Biolegend); B220 (clone RA3-6B2, BD Biosciences); Gr1 (clone RB6-8C5, BD Biosciences); Ter119 (clone TER-119, Biolegend); FcεRIα (clone Mar-1, Biolegend); CD115 (clone AFS98, Biolegend); CD19 (clone 6D5, Biolegend); NK1.1 (clone PK136, Biolegend); CD45 (clone 30-F11, Biolegend); CD4 (clone RM4-5, Biolegend); IL-17A (clone TC11-18H10.1, Biolegend); CD8α (clone 53-6.7, Biolegend); Thy1 (clone 53-2.1, eBioscience); and FoxP3 (clone FJK-16s, eBioscience).
Flow cytometry was performed on a BD FACSAria III cytometer (BD Biosciences RNA-Seq of distal small intestinal gene expression -Total RNA was isolated from the distal third of the small intestines of mice using the RNeasy Mini Kit and the manufacturer's instructions (Qiagen, Hilden, Germany). RNA quality and concentration were determined using a BioAnalyzer Pico kit (Agilent Genomics). Ribosomal RNA was depleted prior to cDNA synthesis and barcoding using the TruSeq Stranded RNA kit (Illumina). cDNA libraries generated from each sample were pooled and sequenced [Illumina NextSeq instrument; 75 nucleotide unidirectional reads; 3.48 x 10 7 ± 2.47 x 10 6 reads/sample (mean ± SD)]. Adapter sequences were removed from the resulting reads and quality trimming was performed using trim_galore (v0.4.1). Release 92 of the mouse genome was downloaded from Ensembl and a STAR-compatible database was generated (STAR v2.5.3a). Quality-controlled reads were mapped to the mouse genome database using STAR with default settings aside from "--outFilterMatchNmin 25" to generate bam-format alignment files. Finally, featureCounts (subread v1.5.3) was used to generate gene counts for downstream statistical analysis. Count tables were read into R (v3.3.1) and analyzed using DESeq2 (v1.14.1) to identify differentially-expressed genes. The resulting tables were filtered to only include genes with an adjusted p-value <0.05 and a fold-difference in expression between the two diet conditions (unsupplemented M8 versus M8 containing S-BMO) of greater than 2-fold (increased or decreased). The analysis produced a list of 164 genes.
Immunohistochemical studies of intestinal sections -The entire length of the small intestine was removed immediately following euthanasia. The intestine was quickly divided into proximal, middle, and distal thirds, and each segment was subdivided into thirds. The proximal third of each segment was fixed in Carnoy's solution (18 h at room temperature), transferred to 70% ethanol, then embedded in paraffin, and 5 µm-thick sections were prepared. Unstained sections were rehydrated and antigen unmasking was performed by boiling in 50 mM sodium citrate buffer (pH 6) for 20 minutes. Tuft cells were stained with DCLK1/DCAMKL1(D2U3L) antibody (Cell Signaling Technology, catalog number 62257) diluted 1:300 in a solution containing 20 mM Tris, 130 mM NaCl and 0.1% (v/v) Tween-20. Antigen-antibody complexes were visualized using the EXPOSE rabbit-specific HRP/DAB Detection IHC Kit (Abcam) and betazoid 3, 3' diaminobenzidine (DAB) chromogen. Stained sections were washed with Tris/NaCl/Tween-20 and nuclei were visualized with hematoxylin (Leica). A 20X field of view containing the greatest number of DCLK1-positive cells in a given section of a given small intestinal segment was identified by a pathologist blinded to mouse treatment group. An image was captured (Olympus IX70 microscope), converted to greyscale, and digital image analysis was performed using standard ImageJ 1.51h program features along with the IHC Image Analysis Toolbox and the Trainable Segmentation plugins.
Protein quantification -The cecum was removed from each mouse and after harvest of luminal contents the remaining tissue was rinsed gently with PBS. The proximal third of the cecum was combined with 1.6 mm diameter aluminum oxide particles and 1.6 mm diameter silicon particles (Lysing Matrix F; MP Biomedicals) and 400 µL lysis buffer I [1x HALT Protease Inhibitor (Pierce), 5 mM HEPES]. The tissue was disrupted using a Mini-Beadbeater (BioSpec Products) for 2 minutes at room temperature. 400 µL of Lysis Buffer II [1x HALT Protease Inhibitor (Pierce), 5 mM HEPES, 2% Triton X-100] was added to the homogenate, which was incubated on ice for 30 minutes, followed by centrifugation (13,000 x g for 5 minutes at 4°C). The concentration of total protein in the resulting supernatant was determined by a bicinchoninic acid (BCA) assay according to manufacturer's instructions (Pierce). The mouse serum and plasma proteins described in Dataset S2 were quantified using the 
